Omniscope — Seed

Buenavista Equity Partners announced a strategic investment, through its Buenavista Ventures strategy, in Omniscope, a Barcelona company at the intersection of biotechnology and data science that is building what it calls the world's largest immunological database using proprietary lab technology and AI. The amount was not disclosed and no lead investor was stated.